Intellia Therapeutics Announces Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Intellia Therapeutics Announces Second Quarter 2020 Financial Results

Intellia Therapeutics (NTLA) Tops Q2 EPS by 8c, Revenues Beat

August 6, 2020 8:07 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q2 EPS of ($0.61), $0.08 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $16.26 million versus the consensus estimate of $8.54 million.

We are very... More